Establishment Labs  Inc. logo

Establishment Labs Inc.

ESTA | NASDAQ
Chart Builder DCF Calculator
$70.70
+$2.96 (+4.37%)
Sep 22, 2026, 11:11 AM ET · Market open

Company Profile

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

Key Executives

Name Position
Fillipo Peter Caldini Chief Executive Officer & Director
Roberto de Mezerville Chief Technology Officer
Cassandra E. Harris Senior VP & CFO
Ivan Bilic Senior Vice President of Commercial Operations - OUS
Jeff Ehrhard Senior Vice President & GM of North America
Juan Jose Chacon Quiros Founder & Executive Director
Malavika William VP, Global Head of Marketing & Communications
Rajbir Singh Denhoy Senior Vice President of Global Strategy
S. Ross Mansbach General Counsel, Chief Compliance Officer & Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Aug 26, 2026 4 Filing
Aug 07, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 31, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 28, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 10, 2026 4 Filing
Jul 10, 2026 4 Filing
Jul 01, 2026 4/A [Amend] Filing
Jul 01, 2026 4 Filing
Jul 01, 2026 4 Filing
View All SEC Filings
Establishment Labs Inc.
Establishment Labs  Inc. logo
Country United States
IPO Date Jul 18, 2018
Industry Medical - Devices
Sector Healthcare
Employees 1,004
CEO Fillipo Peter Caldini

Contact Details

11401 century oaks terrace Austin, Texas 78758 United States

Stock Details

Ticker Symbol ESTA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001688757
CUSIP Number G31249108
ISIN Number VGG312491084
SIC Code 3842

© 2026 bestshares.com. All rights reserved.